228 related articles for article (PubMed ID: 28165585)
61. [Progress in Examination and Treatment of Hepatitis C Virus].
Suda G; Sakamoto N
Rinsho Byori; 2015 Jun; 63(6):762-7. PubMed ID: 26548242
[TBL] [Abstract][Full Text] [Related]
62. Hepatitis C Virus Diagnosis and the Holy Grail.
Applegate TL; Fajardo E; Sacks JA
Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
[TBL] [Abstract][Full Text] [Related]
63. Re-re-treatment of hepatitis C virus: Eight patients who relapsed twice after direct-acting-antiviral drugs.
Hartman J; Bichoupan K; Patel N; Chekuri S; Harty A; Dieterich D; Perumalswami P; Branch AD
World J Gastroenterol; 2015 Nov; 21(43):12430-8. PubMed ID: 26604650
[TBL] [Abstract][Full Text] [Related]
64. Hepatitis C virus infection and chronic renal disease: A review.
Goel A; Bhadauria DS; Aggarwal R
Indian J Gastroenterol; 2018 Nov; 37(6):492-503. PubMed ID: 30560540
[TBL] [Abstract][Full Text] [Related]
65. Hepatitis C Virus and Interferon-Free Antiviral Therapeutics Revolution: Implications for Pakistan.
Afzal MS
Viral Immunol; 2017 May; 30(4):252-257. PubMed ID: 28118096
[TBL] [Abstract][Full Text] [Related]
66. Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
Martin MT; Deming P
Pharmacotherapy; 2017 Jun; 37(6):735-747. PubMed ID: 28374965
[TBL] [Abstract][Full Text] [Related]
67. The era of direct-acting antivirals has begun: the beginning of the end for HCV?
Vachon ML; Dieterich DT
Semin Liver Dis; 2011 Nov; 31(4):399-409. PubMed ID: 22189979
[TBL] [Abstract][Full Text] [Related]
68. Should all dialysis patients with hepatitis C be treated? If so, before or after kidney transplantation?
Jadoul M; Martin P
Semin Dial; 2017 Sep; 30(5):395-397. PubMed ID: 28786139
[TBL] [Abstract][Full Text] [Related]
69. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Awan AAY; Berenguer MC; Bruchfeld A; Fabrizi F; Goldberg DS; Jia J; Kamar N; Mohamed R; Pessôa MG; Pol S; Sise ME; Balk EM; Gordon CE; Adam G; Cheung M; Earley A; Martin P; Jadoul M
Ann Intern Med; 2023 Dec; 176(12):1648-1655. PubMed ID: 38079642
[TBL] [Abstract][Full Text] [Related]
70. Hepatitis C virus infection in end stage renal disease and after kidney transplant.
Rodriguez-Castro KI; Morisco F; Rigotti P; Rugge M; Burra P
J Gastrointestin Liver Dis; 2014 Sep; 23(3):340-2. PubMed ID: 25267966
[No Abstract] [Full Text] [Related]
71. Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.
Everson GT; Sims KD; Rodriguez-Torres M; Hézode C; Lawitz E; Bourlière M; Loustaud-Ratti V; Rustgi V; Schwartz H; Tatum H; Marcellin P; Pol S; Thuluvath PJ; Eley T; Wang X; Huang SP; McPhee F; Wind-Rotolo M; Chung E; Pasquinelli C; Grasela DM; Gardiner DF
Gastroenterology; 2014 Feb; 146(2):420-9. PubMed ID: 24184132
[TBL] [Abstract][Full Text] [Related]
72. Prevalence of hepatitis C virus infection and genotypes in patient with chronic kidney disease undergoing hemodialysis.
de Jesus Rodrigues de Freitas M; Fecury AA; de Almeida MK; Freitas AS; de Souza Guimarães V; da Silva AM; da Costa YF; da Costa RA; Ferreira P; Martins LC
J Med Virol; 2013 Oct; 85(10):1741-5. PubMed ID: 23852735
[TBL] [Abstract][Full Text] [Related]
73. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
Intern Emerg Med; 2018 Dec; 13(8):1139-1166. PubMed ID: 30255464
[TBL] [Abstract][Full Text] [Related]
74. Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population.
Sikavi C; Chen PH; Lee AD; Saab EG; Choi G; Saab S
Hepatology; 2018 Mar; 67(3):847-857. PubMed ID: 29108121
[TBL] [Abstract][Full Text] [Related]
75. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
Liu CH; Kao JH
J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
[TBL] [Abstract][Full Text] [Related]
76. [New possibilities on the horizon for the treatment of hepatitis C virus infection: direct-acting antiviral therapy].
Pár A
Orv Hetil; 2010 Dec; 151(50):2045-56. PubMed ID: 21126947
[TBL] [Abstract][Full Text] [Related]
77. Hepatitis C Virus: Viral Quasispecies and Genotypes.
Tsukiyama-Kohara K; Kohara M
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271914
[TBL] [Abstract][Full Text] [Related]
78. Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.
Preciado MV; Valva P; Escobar-Gutierrez A; Rahal P; Ruiz-Tovar K; Yamasaki L; Vazquez-Chacon C; Martinez-Guarneros A; Carpio-Pedroza JC; Fonseca-Coronado S; Cruz-Rivera M
World J Gastroenterol; 2014 Nov; 20(43):15992-6013. PubMed ID: 25473152
[TBL] [Abstract][Full Text] [Related]
79. Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
Desnoyer A; Pospai D; Lê MP; Gervais A; Heurgué-Berlot A; Laradi A; Harent S; Pinto A; Salmon D; Hillaire S; Fontaine H; Zucman D; Simonpoli AM; Muret P; Larrouy L; Bernard Chabert B; Descamps D; Yazdanpanah Y; Peytavin G
J Hepatol; 2016 Jul; 65(1):40-47. PubMed ID: 26952005
[TBL] [Abstract][Full Text] [Related]
80. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
